Acta Med. 2010, 53: 73-77

https://doi.org/10.14712/18059694.2016.63

Regulatory T cells (Treg) and Their Roles in Immune System with Respect to Immunopathological Disorders

Kateřina Kondělkováa, Doris Vokurkováa, Jana Krejseka, Lenka Borskáb, Zdeněk Fialac, Ctirad Andrýsa

aCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Institute of Pathological Physiology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Institute of Hygiene and Preventive Medicine, Hradec Králové, Czech Republic

Received January 21, 2010
Accepted March 18, 2010

References

1. Battaglia M, Gregori S, Bacchetta R, Roncarolo M-G. Tr1 cells: from discovery to their clinical application. Semin Immunol 2006; 18(2):120–7. <https://doi.org/10.1016/j.smim.2006.01.007>
2. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235–8. <https://doi.org/10.1038/nature04753>
3. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115:2904–13. <https://doi.org/10.1172/JCI23961> <PubMed>
4. Dieckmann D, Plotter H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of Cd4+Cd25+ T cells with regulatory properties from human blood. J Exp Med 2001, 193(11):1303–10. <https://doi.org/10.1084/jem.193.11.1303> <PubMed>
5. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329–41. <https://doi.org/10.1016/j.immuni.2005.01.016>
6. Fontenot JD, Rudensky A. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6:331–7. <https://doi.org/10.1038/ni1179>
7. Franz B, Fritzsching B, Riehl A. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 2007; 56(6):1910–20. <https://doi.org/10.1002/art.22699>
8. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2006; 6:169–75. <https://doi.org/10.1016/j.autrev.2006.10.002>
9. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting Edge: Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783–6. <https://doi.org/10.4049/jimmunol.174.4.1783>
10. Grant J, Bourcier K, Wallace S, et al. Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patiens. Cytometry B Clin Cytom 2009; 76B: 69–78. <https://doi.org/10.1002/cyto.b.20446>
11. Grossman WJ, Verbsky JW, Barchet W, Collona M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21:589–601. <https://doi.org/10.1016/j.immuni.2004.09.002>
12. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The Majority of Human Peripheral Blood CD4+CD25highFoxp3+ Regulatory T Cells Bear Functional Skin-Homing Receptors. J Imunol 2006; 177:4488–94. <https://doi.org/10.4049/jimmunol.177.7.4488>
13. Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, Durum SK. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth factor rev 1999; 10:41–60. <https://doi.org/10.1016/S1359-6101(98)00025-2>
14. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057–61. <https://doi.org/10.1126/science.1079490>
15. Huber S, Schramm C, Lehr HA, et al. Cutting Edge: TGF-β signaling si required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 2004; 173:6526–31. <https://doi.org/10.4049/jimmunol.173.11.6526>
16. Chen L, Shen Z, Wang G, Fan P, Liu Y. Dynamic frequency of CD4+CD25+ Foxp3+ Treg cells in Psoriasis vulgaris. J Dermatol Sci 2008 51(3):200–3. <https://doi.org/10.1016/j.jdermsci.2008.04.015>
17. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193:1285–94. <https://doi.org/10.1084/jem.193.11.1285> <PubMed>
18. Kimball AB, Kupper TS. Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology. Clin Dermatol 2008; 26:554–61. <https://doi.org/10.1016/j.clindermatol.2007.11.007>
19. Kursar M, Bonhagen K, Fensterle J, et al. Regulatory CD4+CD25+ T Cells Restrict Memory CD8+ T Cell Responses. J Exp Med 2002; 196(12):1585–92. <https://doi.org/10.1084/jem.20011347> <PubMed>
20. Lan RY, Mackay JR, Gershwin ME. Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the bordur. J Autoimmun 2007; 29:272–80. <https://doi.org/10.1016/j.jaut.2007.07.021> <PubMed>
21. Li Y-YY, Zollner TM, Schön MP. Targeting leukocyte recruitment in the treatment of psoriasis. Clin Dermatol 2008; 26:527–38. <https://doi.org/10.1016/j.clindermatol.2007.11.002>
22. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203:1701–11. <https://doi.org/10.1084/jem.20060772> <PubMed>
23. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005, 201(7):1061–7. <https://doi.org/10.1084/jem.20042276> <PubMed>
24. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145–73. <https://doi.org/10.1146/annurev.iy.07.040189.001045>
25. Ochs HD, Oukka M, Torgerson TR. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 2009; 123(5):977–83. <https://doi.org/10.1016/j.jaci.2009.03.030> <PubMed>
26. Piccirillo CA, Shevach EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Imunol 2001; 167:1137–40. <https://doi.org/10.4049/jimmunol.167.3.1137>
27. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182:68–79. <https://doi.org/10.1034/j.1600-065X.2001.1820105.x>
28. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151–64.
29. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6:345–52. <https://doi.org/10.1038/ni1178>
30. Sugiyama H, Gyulai R, Toichi E, et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174: 164–73. <https://doi.org/10.4049/jimmunol.174.1.164> <PubMed>
31. Taams LS, Van Amelsfort JM, Tiemessen MM, et al. Modulation of monocyte/ macrophage function by human CD4+CD25+ regulatory T cells. Hum Imunol 2005; 66:222–30. <https://doi.org/10.1016/j.humimm.2004.12.006> <PubMed>
32. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells supress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287–96. <https://doi.org/10.1084/jem.188.2.287> <PubMed>
33. Trzonkowski P, Szmit E, Mysliwska J, Dobyszuk A, Myśliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004; 112:258–67. <https://doi.org/10.1016/j.clim.2004.04.003>
34. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17–producing T cells. Immunity 2006; 24:179–89. <https://doi.org/10.1016/j.immuni.2006.01.001>
35. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006; 117(1):176–83. <https://doi.org/10.1016/j.jaci.2005.10.040>
36. Veselá I, Stříž I. T regulační buňky a jejich úloha v imunitních reakcích. Alergie 2004; 1:43–52.
37. Vojdani A, Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). eCAM 2006; 3(3):309–16.
38. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25+ Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells. J Immunol 2007, 178(4):2018–27. <https://doi.org/10.4049/jimmunol.178.4.2018>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive